CD44 and breast carcinoma: In CD44+/CD24neg/low and CD44+/CD24+ tumorigenic cell populations derived from basal-like breast cancer cells, non-cytotoxic concentrations of metformin (1 mM) suppressed the occurrence of stem-cell-like characteristics by the suppression of EMT [258].